Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    CYP17 and breast cancer: no overall effect, but what about interactions?

    Little J, Simard J.

    Breast Cancer Res. 2005;7(6):238-42. Epub 2005 Sep 20.

    PMID:
    16280038
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

    Ye Z, Parry JM.

    Mutagenesis. 2002 Mar;17(2):119-26.

    PMID:
    11880540
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.

    Verla-Tebit E, Wang-Gohrke S, Chang-Claude J.

    Breast Cancer Res. 2005;7(4):R455-64. Epub 2005 Apr 12.

    PMID:
    15987450
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.

    Chacko P, Rajan B, Mathew BS, Joseph T, Pillai MR.

    Breast Cancer. 2004;11(4):380-8.

    PMID:
    15604994
    [PubMed - indexed for MEDLINE]
    5.

    CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.

    Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, Saxena S.

    J Hum Genet. 2007;52(2):159-65. Epub 2007 Jan 18.

    PMID:
    17235448
    [PubMed - indexed for MEDLINE]
    6.

    Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.

    Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, Chen Q.

    Breast Cancer Res Treat. 2010 Jul;122(1):259-65. Epub 2009 Dec 24.

    PMID:
    20033766
    [PubMed - indexed for MEDLINE]
    7.

    CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.

    Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB.

    Breast Cancer Res. 2005;7(4):R513-21. Epub 2005 May 12.

    PMID:
    15987458
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Genetic polymorphism of CYP17 and breast cancer risk in Korean women.

    Shin MH, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY, Park SK, Noh DY, Ahn SH, Kim B, Kang D.

    Exp Mol Med. 2005 Feb 28;37(1):11-7.

    PMID:
    15761247
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

    Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

    Breast Cancer Res Treat. 2009 Mar;114(2):327-38. Epub 2008 Jul 16.

    PMID:
    18629629
    [PubMed - indexed for MEDLINE]
    10.

    Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.

    Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H.

    Carcinogenesis. 2008 Apr;29(4):766-71. Epub 2008 Feb 14.

    PMID:
    18281250
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.

    Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J.

    J Nutr. 2006 Jun;136(6):1596-603.

    PMID:
    16702327
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

    Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, Berglund G, Buring J, Calle EE, Clavel-Chapelon F, Cox DG, Gaziano JM, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn J, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Ma J, Le Marchand L, Linseisen J, Lund E, Navarro C, Overvad K, Palli D, Peeters PH, Pike MC, Riboli E, Stampfer MJ, Thun MJ, Travis R, Trichopoulos D, Yeager M, Ziegler RG, Spencer Feigelson H, Chanock SJ.

    Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2237-46.

    PMID:
    18006912
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.

    Ahsan H, Whittemore AS, Chen Y, Senie RT, Hamilton SP, Wang Q, Gurvich I, Santella RM.

    Breast Cancer Res. 2005;7(1):R71-81. Epub 2004 Nov 11.

    PMID:
    15642171
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    CYP17 (T34C), CYP19 (Trp39Arg), and FGFR2 (C906T) polymorphisms and the risk of breast cancer in south Indian women.

    Samson M, Rama R, Swaminathan R, Sridevi V, Nancy KN, Rajkumar T.

    Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):111-4.

    PMID:
    19469636
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.

    Kuligina ES, Togo AV, Suspitsin EN, Grigoriev MY, Pozharisskiy KM, Chagunava OL, Berstein LM, Theillet C, Hanson KP, Imyanitov EN.

    Cancer Lett. 2000 Aug 1;156(1):45-50.

    PMID:
    10840158
    [PubMed - indexed for MEDLINE]
    16.

    [Relationship between estrogen-biosynthesis gene (CYP17, CYP19, HSD17beta1) polymorphisms and breast cancer].

    Wang YP, Li H, Li JY, Yuan P, Yang F, Lei FM, Pang Y, Guo J.

    Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):899-903. Chinese.

    PMID:
    20193327
    [PubMed - indexed for MEDLINE]
    17.

    Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.

    Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL.

    Genet Epidemiol. 2003 Apr;24(3):161-72.

    PMID:
    12652520
    [PubMed - indexed for MEDLINE]
    18.

    Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women.

    Onland-Moret NC, van Gils CH, Roest M, Grobbee DE, Peeters PH.

    Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):815-20.

    PMID:
    15824149
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.

    Yao L, Fang F, Wu Q, Yang Z, Zhong Y, Yu L.

    Breast Cancer Res Treat. 2010 Jul;122(1):221-7. Epub 2009 Dec 15.

    PMID:
    20013047
    [PubMed - indexed for MEDLINE]
    20.

    Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer.

    Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF.

    Breast Cancer Res Treat. 2004 Dec;88(3):217-30.

    PMID:
    15609124
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk